Tectonic Therapeutic Shares Are Trading Higher After Piper Sandler Initiated Coverage With an Overweight Rating and Announced a Price Target of $76.
Tectonic Therapeutic Shares Are Trading Higher After Piper Sandler Initiated Coverage With an Overweight Rating and Announced a Price Target of $76.
派傑投資公佈報告，給予Tectonic Therapeutic超配的評級，目標價76美元，其後該股股價上漲。
Tectonic Therapeutic Shares Are Trading Higher After Piper Sandler Initiated Coverage With an Overweight Rating and Announced a Price Target of $76.
派傑投資公佈報告，給予Tectonic Therapeutic超配的評級，目標價76美元，其後該股股價上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。